4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-030443
Chief Scientific Officer sold 2,081 shares at $25.70 ($53,482)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-03-11 | Sale 10b5-1 | −2,081 | $25.70 | $53,482 | 152,352 | D |
| Open-market sales · 2,081 sh · avg $25.70 · $53,482 | |||||||
Loading xslF345X05/ownership.xml…